5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: A systematic review
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Photodiagnosis and photodynamic therapy
- Publicado em
- 24 mai 2025
- Citações
- 11
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: A systematic review
Nathalie C Zeitouni, Todd Schlesinger, Meenal Kheterpal, Puneet S Jolly, Jared Jagdeo
Descritores MeSH
- Aminolevulinic Acid
- Skin Neoplasms
- Photosensitizing Agents
- Basal Cell Carcinoma
- Carcinoma, Squamous Cell
- Photochemotherapy
- Bowen's Disease
- Humans
Veja também
Estudos relacionados
- Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial
- Durable Clearance Rate of Photodynamic Therapy for Bowen Disease and Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
- Cost-Effectiveness of Photodynamic Therapy and 5-Fluorouracil Cream versus Surgical Excision in Treatment of Bowen's Disease: A Trial-Based Economic Evaluation
- Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study